Back

Outcome of percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in patients with STEMI as compared to stable CAD 2 year results from the German-Austrian ABSORB

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Coronary artery disease: revascularisation 2 Revascularisation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Monique Troebs

Friedrich Alexander University Erlangen Nuernberg, Erlangen (Germany)

5 More presentations in this session

Presentation thumbnail
Efficacy of the three dimensional wiring technique for CTO
Doctor K. Tanaka (Osaka, JP)
Abstract
Presentation thumbnail
The greater baseline rate of in-stent restenosis in diabetics treated with coronary angioplasty and rotablation is not related to the greater periprocedural complication rate or poorer procedural effe
Professor R. Januszek (Krakow, PL)
Abstract
Presentation thumbnail
Trends of in-hospital mortality and constituent ratio of patients with acute myocardial infarction
Doctor Z. Wang (Beijing, CN)
Abstract Slides
Presentation thumbnail
Prognosis of acute myocardial infarction complicated by cardiogenic shock in the modern era of interventions
Doctor G. Barczi (Budapest, HU)
Abstract
Presentation thumbnail
Same day discharge is safe in selected patients undergoing NSTE-ACS
Doctor A. Paterson (Cupar, GB)

Access the full session

Session thumbnail
Poster Session 1 - Coronary artery disease: revascularisation 2

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources